Prosecution Insights
Prosecution Insights
124 pending office actions • 91 clients • 115 examiners • 65 art units • 0 of 124 (0%) have an AI response strategy ready • 133 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 124 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 124 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 6 (5%) |
| §103 only | 75 (60%) |
| §102 only | 8 (6%) |
| §112 only | 13 (10%) |
| No statute on record | 22 (18%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BEANE, RANDALL L | 3 | 32.5% | +37.8% |
| VIJAYARAGHAVAN, JAGAMYA NMN | 2 | 67.7% | +39.0% |
| SCHUBERG, LAURA J | 2 | 23.7% | +36.7% |
| TRAN, CHRISTINA L | 2 | 46.8% | +51.2% |
| MEYERING, SHABANA SHABBEER | 2 | 71.2% | +37.8% |
| TRAN, KHOA NHAT | 2 | 35.4% | +66.3% |
| NOBLE, MARCIA STEPHENS | 2 | 67.0% | +40.2% |
| REYNOLDS, FRED H | 2 | 33.0% | +39.2% |
| COOK, JONATHON | 1 | 81.6% | +17.6% |
| HUNNINGS, TRAVIS R | 1 | 82.9% | +13.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18980973 | MULTISENSOR BRACELET | HUNNINGS, TRAVIS R | 22d |
| 19055839 | OPTICAL MICROSCOPY | COOK, JONATHON | 36d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18379970 | APPARATUS AND METHOD FOR PRODUCING THREE-DIMENSIONAL OBJECTS | TAUFIQ, FARAH N | 58d overdue |
| 18635272 | SYSTEM AND PROGRAM FOR COGNITIVE SKILL TRAINING | LANE, DANIEL E | 49d overdue |
| 17510981 | METHOD FOR OBTAINING IMMUNO-STIMULATORY DENDRITIC CELLS | SCHUBERG, LAURA J | 44d overdue |
| 18010513 | MATURED THREE-DIMENSIONAL PRINTED COMPOSITIONS AND USES THEREOF | SCHUBERG, LAURA J | 37d overdue |
| 17629313 | PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF | NIEBAUER, RONALD T | 3d overdue |
| 18024624 | PEPTIDES ENDOWED WITH ANGIOGENIC ACTIVITY | FISHER, MELISSA L | 5d |
| 17427453 | ANTIMICROBIAL ENDOLYSIN POLYPEPTIDES, COMPOSITIONS AND FORMULATIONS | HELLMAN, KRISTINA M | 7d |
| 18037117 | SYSTEM FOR SENSING EEG SIGNALS ON A LIVING BEING, AND SYSTEM FOR ELECTRICALLY STIMULATING TISSUE OF A LIVING BEING | BERHANU, ETSUB D | 76d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17425058 | METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF OCULAR DISEASES AND CONDITIONS | TRAN, CHRISTINA L | 132d overdue |
| 15771043 | NOVEL POLYPEPTIDES WITH IMPROVED PROTEOLYTIC STABILITY, AND METHODS OF PREPARING AND USING SAME | REYNOLDS, FRED H | 73d overdue |
| 17510981 | METHOD FOR OBTAINING IMMUNO-STIMULATORY DENDRITIC CELLS | SCHUBERG, LAURA J | 44d overdue |
| 18010513 | MATURED THREE-DIMENSIONAL PRINTED COMPOSITIONS AND USES THEREOF | SCHUBERG, LAURA J | 37d overdue |
| 17440081 | CARDIOMYOCYTE PROLIFERATION | TRAN, KHOA NHAT | 37d overdue |
| 18039812 | RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING MYOTONIC DYSTROPHY TYPE 1 | VIJAYARAGHAVAN, JAGAMYA NMN | 31d overdue |
| 17748323 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN NEURAL PROGENITOR CELLS | TRAN, KHOA NHAT | 10d overdue |
| 18487666 | FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES | BEANE, RANDALL L | 3d overdue |
| Art Unit | Apps |
|---|---|
| 1654 | 7 |
| 1632 | 6 |
| 1658 | 6 |
| 1647 | 5 |
| 1633 | 5 |
| 1637 | 5 |
| 1631 | 4 |
| 1653 | 3 |
| 1622 | 3 |
| 1628 | 3 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19055839 | OPTICAL MICROSCOPY | Cambridge Enterprise Limited | COOK, JONATHON | 2877 | §103 | Non-Final OA | 36d | Pending | Feb 18, 2025 |
| 18980973 | MULTISENSOR BRACELET | Legionarius, LLC | HUNNINGS, TRAVIS R | 2689 | §103 | Non-Final OA | 22d | Pending | Dec 13, 2024 |
| 18818268 | ANTIBODIES WITH FC MODIFICATIONS AND METHODS OF USING THE SAME | The General Hospital Corporation | GUSTILO, ESTELLA M | 1646 | Other | Non-Final OA | 72d overdue | Pending | Aug 28, 2024 |
| 18706302 | DETECTION, STAGING, MONITORING AND TREATING A DISEASE OR A CONDITION | Sunbird Bio, Inc. | BOWERS, ERIN M | 1653 | Other | Non-Final OA | 20d | Pending | Apr 30, 2024 |
| 18704112 | METHODS OF IMPLANTING ENGINEERED TISSUE CONSTRUCTS | Satellite Biosciences, Inc. | JANOSKO, CHASITY PAIGE | 1613 | §103 | Non-Final OA | 6d | Pending | Apr 24, 2024 |
| 18635272 | SYSTEM AND PROGRAM FOR COGNITIVE SKILL TRAINING | Thynk, Inc. | LANE, DANIEL E | 3715 | §101 | Non-Final OA | 49d overdue | Pending | Apr 15, 2024 |
| 18691738 | SYNERGISTIC NANOMEDICINE DELIVERING TOPOISOMERASE I TOXIN (SN-38) AND INHIBITORS OF POLYNUCLEOTIDE KINASE 3'-PHOSPHATASE (PNKP) FOR ENHANCED TREATMENT OF COLORECTAL CANCER | The Governors of the University of Alberta | PROSSER, ALISSA J | 1619 | §103 | Non-Final OA | 53d | Pending | Mar 13, 2024 |
| 18688518 | METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVED DATA SETS | The General Hospital Corporation | RIVERA-MARTINEZ, GUILLERMO M | 2677 | §112 | Non-Final OA | 22d overdue | Pending | Mar 01, 2024 |
| 18681298 | LIPID-BASED COMPOSITION FOR ORAL ADMINISTRATION OF BRADYKININ B2-RECEPTOR ANTAGONISTS | Pharvaris GmbH | TCHERKASSKAYA, OLGA V | 1615 | §112 | Non-Final OA | 31d overdue | Pending | Feb 05, 2024 |
| 18393145 | Preparation Method and Enrichment Method for Cyanidin-3-Diglucoside-5-Glucoside | China Agricultural University | SWIFT, CANDICE LEE | 1657 | Other | Final Rejection | 22d | Pending | Dec 21, 2023 |
| 18564436 | IMPACT CUSHIONING MATERIAL FOR PADDED GLOVES USED IN CONTACT SPORTS | Hayabusa Fightwear Inc. | MARIN, DAKOTA | 3732 | §103 | Non-Final OA | 86d overdue | Pending | Nov 27, 2023 |
| 18563504 | REACTOR PLANT AND METHOD TO CONTROL PERFORMANCE | Electrochaea GmbH | HOBBS, MICHAEL L | 1799 | §112 | Final Rejection | 7d | Pending | Nov 22, 2023 |
| 18290356 | NOVEL PROTEIN AND NUCLEIC ACID SEQUENCES FOR COVID-19 VACCINES | Dompe' Farmaceutici Spa | ZOU, NIANXIANG | 1671 | §103 | Non-Final OA | 40d | Pending | Nov 13, 2023 |
| 18487666 | FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES | Zealand Pharma A/S | BEANE, RANDALL L | 1654 | §103 | Final Rejection | 3d overdue | Pending | Oct 16, 2023 |
| 18379970 | APPARATUS AND METHOD FOR PRODUCING THREE-DIMENSIONAL OBJECTS | Q.Big 3D GmbH | TAUFIQ, FARAH N | 1754 | §101 | Non-Final OA | 58d overdue | Pending | Oct 13, 2023 |
| 18285560 | METHODS AND COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS | Spirovant Sciences, Inc. | BURKHART, MICHAEL D | 1638 | §103 | Non-Final OA | 44d overdue | Pending | Oct 04, 2023 |
| 18371694 | APPARATUS AND METHOD FOR INDUCING HUMAN OOCYTE MATURATION IN VITRO | Gameto, Inc. | CORDAS, EMILY ANN | 1632 | §103 | Final Rejection | 8d | Pending | Sep 22, 2023 |
| 18282426 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH HYPERMINERALIZATION | Université De Lausanne | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | §112 | Non-Final OA | 36d | Pending | Sep 15, 2023 |
| 18282357 | C5AR1 INHIBITORS FOR TREATING HYPERSENSITIVITY REACTIONS TO TAXANES | Dompe' Farmaceutici Spa | GURLEY, JAMI MICHELLE | 1647 | Other | Non-Final OA | 43d | Pending | Sep 15, 2023 |
| 18281346 | COMPOSITIONS AND METHODS FOR TREATING X-LINKED MYOTUBULAR MYOPATHY | Audentes Therapeutics, Inc. | DITMER, KATHRYN ELIZABETH | 3785 | §103 | Non-Final OA | 19d | Pending | Sep 11, 2023 |
| 18244773 | GONADOTROPIN-RELEASING HORMONE ANTAGONIST DOSING REGIMENS FOR TREATING UTERINE FIBROIDS AND REDUCING MENSTRUAL BLOOD LOSS | Kissei Pharmaceutical Co., Ltd. | COPPINS, JANET L | 1628 | §103 | Final Rejection | 22d | Pending | Sep 11, 2023 |
| 18279708 | CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE IN THE TREATMENT OF SEIZURES | Dompe' Farmaceutici Spa | DAHLIN, HEATHER RAQUEL | 1629 | Other | Non-Final OA | 15d | Pending | Aug 31, 2023 |
| 18279517 | THE USE OF EMPAGLIFLOZIN FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE | The Governors of the University of Alberta | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §103 | Non-Final OA | 46d overdue | Pending | Aug 30, 2023 |
| 18276709 | PHARMACEUTICALLY ACCEPTABLE SALTS OF PSILOCIN AND USES THEREOF | Eleusis Therapeutics US, Inc. | JACKSON, SHAWQUIA | 1626 | Other | Non-Final OA | 35d overdue | Pending | Aug 10, 2023 |
| 17625380 | MAGEA10 SPECIFIC T CELL RECEPTORS AND THEIR USE | Medigene Immunotherapies GmbH | ALLEN, MARIANNE P | 1647 | §103 | Non-Final OA | 17d overdue | Pending | Jul 27, 2023 |
| 18034254 | OCULAR-TENSION-INCREASING AGENT CAPABLE OF BEING DEPRIVED OF DRUG ACTIVITY BY TEMPERATURE CONTROL | Tohoku University | SONG, JIANFENG | 1613 | §103 | Non-Final OA | 111d overdue | Pending | Jul 21, 2023 |
| 18272168 | CD64 CHIMERIC RECEPTOR AND USES THEREOF | CONSIGLIO NAZIONALE DELLE RICERCHE | DRISCOLL, LORA E BARNHART | 3991 | §103 | Non-Final OA | 30d overdue | Pending | Jul 13, 2023 |
| 18268139 | USE OF GLP-2 ANALOGUES IN PATIENTS WITH RENAL INSUFFICIENCY | Zealand Pharma A/S | BOWLES, DAVID PAUL | 1654 | §103 | Non-Final OA | 25d overdue | Pending | Jun 21, 2023 |
| 18267230 | METHOD FOR MASS PRODUCTION OF HIGHLY PURE, STEM CELL-DERIVED EXTRACELLULAR VESICLE BY USING PEPTIDE | Konkuk University Industrial Cooperation Corp. | NGUYEN, NGHI V | 1653 | Other | Non-Final OA | 28d | Pending | Jun 14, 2023 |
| 18256304 | METHOD OF TREATING HEREDITARY HEMORRHAGIC TELANGIECTASIA USING PAZOPANIB | Hht Foundation International, Inc. | WORSHAM, JESSICA N | 1615 | §103 | Final Rejection | 83d | Pending | Jun 07, 2023 |
| 18039846 | OLIGONUCLEOTIDES | Oxford University Innovation Limited | OLSON, ALEXANDRA NADINE | 1684 | Other | Non-Final OA | 33d | Pending | Jun 01, 2023 |
| 18039812 | RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING MYOTONIC DYSTROPHY TYPE 1 | Astellas Gene Therapies, Inc. | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §103 | Non-Final OA | 31d overdue | Pending | Jun 01, 2023 |
| 18204342 | METHODS OF VAPOR DEPOSITION OF METAL HALIDES | Trustees Of Tufts College | PENNY, TABATHA L | 1712 | §103 | Non-Final OA | 15d overdue | Pending | May 31, 2023 |
| 18326661 | SEGMENTED GASTROINTESTINAL DEVICES AND METHODS OF USE THEREOF | Morphic Medical, Inc. | YANG, CHENG FONG | 3781 | §103 | Final Rejection | 37d overdue | Pending | May 31, 2023 |
| 18201498 | PREFERRED ORAL TESTOSTERONE UNDECANOATE THERAPY TO ACHIEVE TESTOSTERONE REPLACEMENT TREATMENT | Marius Pharmaceuticals, Inc. | MOU, LIYUAN | 1628 | Other | Non-Final OA | 18d overdue | Pending | May 24, 2023 |
| 18037117 | SYSTEM FOR SENSING EEG SIGNALS ON A LIVING BEING, AND SYSTEM FOR ELECTRICALLY STIMULATING TISSUE OF A LIVING BEING | Precisis GmbH | BERHANU, ETSUB D | 3791 | §101 | Final Rejection | 76d | Pending | May 16, 2023 |
| 18037196 | CYCLOTRON TARGET AND LANTHANUM THERANOSTIC PAIR FOR NUCLEAR MEDICINE | The Governors of the University of Alberta | DAVIS, SHARON M | 3646 | §103 | Non-Final OA | 35d overdue | Pending | May 16, 2023 |
| 18037007 | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF PRETERM LABOR | Xoma (Us) LLC | HUI, SAN MING R | 1627 | §103 | Non-Final OA | 117d overdue | Pending | May 15, 2023 |
| 18314339 | ANTI-TL1A ANTIBODIES AND METHODS OF USE THEREOF | Bristol-Myers Squibb Company | SUNSHINE, HANNAH LOUISE | 1647 | §112 | Non-Final OA | 21d | Pending | May 09, 2023 |
| 18035640 | POLYSACCHARIDES FOR USE IN TREATING SARS-COV-2 INFECTIONS | Ndpd Pharma, Inc. | ANTHOPOLOS, PETER | 1611 | Other | Non-Final OA | 43d overdue | Pending | May 05, 2023 |
| 18140141 | METHODS OF TREATING LYMPHOPENIA | Keros Therapeutics, Inc. | KAUFMAN, CLAIRE M | 1674 | §103 | Non-Final OA | 60d | Pending | Apr 27, 2023 |
| 18299877 | PHARMACEUTICAL COMPOSITIONS OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND METHODS OF USE | Hoffmann-La Roche, Inc. | TRAN HO, LAM THUY VI | 1647 | Other | Non-Final OA | 52d overdue | Pending | Apr 13, 2023 |
| 18031772 | USE OF N-MYRISTOYL TRANSFERASE (NMT) INHIBITORS IN THE TREATMENT OF CANCER, AUTOIMMUNE DISORDERS, AND INFLAMMATORY DISORDERS | Pacylex Pharmaceuticals Inc. | VALENROD, YEVGENY | 1628 | §102 | Final Rejection | 34d | Pending | Apr 13, 2023 |
| 18133900 | DEVICE AND METHOD FOR OBTAINING IMMUNO-STIMULATORY ANTIGEN-PRESENTING CELLS | Yale University | JUEDES, AMY E | 1644 | Other | Non-Final OA | 84d overdue | Pending | Apr 12, 2023 |
| 18030858 | POLAR LIQUIDS WITH HIGH POROSITY AND USES THEREOF | President and Fellows of Harvard College | SMARI, ABDUL-RAHMAN YUSUF WALEED | 1736 | §103 | Non-Final OA | 13d | Pending | Apr 07, 2023 |
| 18030439 | CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES | Max Biology Co. Ltd. | BASQUILL, SEAN M | 1614 | §103 | Final Rejection | 15d overdue | Pending | Apr 05, 2023 |
| 18028662 | ELECTRONIC WASTE COMPOSITE ARTICLE OR MATERIAL AND PROCESS FOR MAKING SAME | Excir Works Corp. | PIRO, NICHOLAS ANTHONY | 1738 | §103 | Non-Final OA | 21d | Pending | Mar 27, 2023 |
| 18028025 | PRAME SPECIFIC T-CELL RECEPTORS AND USES THEREOF | Medigene Immunotherapies GmbH | BUTTICE, AUDREY L | 1647 | §112 | Non-Final OA | 97d overdue | Pending | Mar 23, 2023 |
| 18025459 | DEVICES AND METHODS FOR CONTINUOUS EXTRUSION OF A DRUG INTO THE MOUTH | SynAgile Corporation | WILLIAMS, CATHERINE SERKE | 3993 | §103 | Non-Final OA | 147d overdue | Pending | Mar 09, 2023 |
| 17924496 | COMBINATION THERAPY FOR TTR AMYLOIDOSIS | Neurimmune AG | HOWARD, ZACHARY C | 1674 | §103 | Non-Final OA | 30d overdue | Pending | Mar 06, 2023 |
| 18024624 | PEPTIDES ENDOWED WITH ANGIOGENIC ACTIVITY | Dompe' Farmaceutici Spa | FISHER, MELISSA L | 1658 | §101 | Non-Final OA | 5d | Pending | Mar 03, 2023 |
| 18024179 | METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVED DATA SETS | The General Hospital Corporation | TRAN, DUY ANH | 2674 | §103 | Non-Final OA | 132d overdue | Pending | Mar 01, 2023 |
| 18021979 | PEPTIDE FOR THERAPEUTIC APPLICATIONS IN THE DERMATOLOGICAL FIELD | Dompe' Farmaceutici S.p.A. | DONOGHUE, BRITTNEY ERIN | 1675 | §103 | Non-Final OA | 14d | Pending | Feb 17, 2023 |
| 18021912 | CONFORMATION-SPECIFIC ANTIBODIES THAT BIND TAU PROTEIN AND USES THEREOF | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | WEN, SHARON X | 1641 | Other | Non-Final OA | 19d | Pending | Feb 17, 2023 |
| 18165613 | CELL MEMBRANE PENETRATING CONJUGATES | Cygenica Limited | VARADARAJ, ARCHANA | 1658 | Other | Non-Final OA | 56d overdue | Pending | Feb 07, 2023 |
| 18163810 | OBINUTUZUMAB TREATMENT OF A DLBCL PATIENT SUBGROUP | Bruker Spatial Biology, Inc. | LU, CHENG | 1642 | Other | Non-Final OA | 32d overdue | Pending | Feb 02, 2023 |
| 18019166 | METHODS FOR LEACHING AND RECOVERY OF PLATINUM GROUP METALS IN ORGANIC SOLVENTS | Excir Works Corp. | MCGUTHRY BANKS, TIMA MICHELE | 1733 | §112 | Final Rejection | 53d | Pending | Feb 01, 2023 |
| 18014906 | METHODS AND COMPOSITIONS FOR TREATING EPILEPSY | Uniqure France | ZARA, JANE J | 1637 | §102 | Non-Final OA | 33d | Pending | Jan 06, 2023 |
| 18014977 | COMPOUNDS FOR USE IN THE TREATMENT OF EPILEPSY | Centre National De La Recherche Scientifique | BABIC, CHRISTOPHER M | 1633 | §112 | Non-Final OA | 46d overdue | Pending | Jan 06, 2023 |
| 18014701 | INTERFEROMETRIC SCATTERING CORRELATION (ISCORR) MICROSCOPY | Cambridge Enterprise Limited | AMARA, MOHAMED K | 2877 | §103 | Final Rejection | 71d overdue | Pending | Jan 05, 2023 |
| 18014561 | COMPOSITIONS AND METHODS FOR TARGETING TUMOR ASSOCIATED TRANSCRIPTION FACTORS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | §103 | Non-Final OA | 131d overdue | Pending | Jan 05, 2023 |
| 18010513 | MATURED THREE-DIMENSIONAL PRINTED COMPOSITIONS AND USES THEREOF | Auregen Biotherapeutics SA | SCHUBERG, LAURA J | 1631 | §103 | Non-Final OA | 37d overdue | Pending | Dec 15, 2022 |
| 18009495 | NEW DRUG DELIVERY SYSTEM FOR OPHTHALMIC USE | Dompe' Farmaceutici S.p.A. | OLSEN, KAELEIGH ELIZABETH | 1619 | §103 | Final Rejection | 5d | Pending | Dec 09, 2022 |
| 18061755 | COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CANINES AND METHODS OF USE | Invetx, Inc. | DAHLE, CHUN WU | 1641 | Other | Non-Final OA | 7d | Pending | Dec 05, 2022 |
| 18071388 | METHODS AND COMPOSITIONS FOR MAINTAINING AND EXPANDING HEMATOPOIETIC STEM CELLS | Trailhead Biosystems Inc. | TAKENAKA, RISA | 1632 | §103 | Non-Final OA | 31d overdue | Pending | Nov 29, 2022 |
| 17924425 | POLYNUCLEOTIDE ARRAYS | Oxford University Innovation Limited | ZHANG, KAIJIANG | 1684 | §102 | Non-Final OA | 30d overdue | Pending | Nov 10, 2022 |
| 17919144 | B CELL IMMUNOMODULATORY THERAPY FOR ACUTE RESPIRATORY DISTRESS SYNDROME | Holy Cross Hospital, Inc. | TIWARI, VYOMA SHUBHAM | 1634 | §103 | Final Rejection | 30d | Pending | Oct 14, 2022 |
| 17957780 | ENVIRONMENT FRIENDLY COLD RAMMING MIXTURE | Hindalco Industries Limited | KOLB, KATARZYNA I | 1767 | §103 | Non-Final OA | 8d overdue | Pending | Sep 30, 2022 |
| 17939198 | THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDERS | Yamaguchi University | CHANDRAKUMAR, NIZAL S | 1625 | §103 | Final Rejection | 49d overdue | Pending | Sep 07, 2022 |
| 17909696 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS | Endolytix Technology, Inc. | KAMM, JUDITH MARIE | 1611 | §103 | Final Rejection | 7d | Pending | Sep 06, 2022 |
| 17896781 | Methods and Compositions for Generating Human Forebrain Neural Progenitor Cells and for Maturation Thereof to Parvalbumin+ Interneurons | Trailhead Biosystems Inc. | SPENCER, ANDREA LYNNE MORRIS | 1631 | §103 | Non-Final OA | 14d | Pending | Aug 26, 2022 |
| 17800639 | CXCL8 (INTERLEUKIN-8) ACTIVITY INHIBITOR AND CORTICOSTEROID COMBINATION AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | Dompe' Farmaceutici Spa | LEE, ANDREW P | 1691 | §103 | Final Rejection | 19d overdue | Pending | Aug 18, 2022 |
| 17819591 | PREPARATION AND COMPOSITION OF INTER-ALPHA INHIBITOR PROTEINS FROM HUMAN PLASMA FOR THERAPEUTIC USE | Prothera Biologics, Inc. | ORWIG, KEVIN S | 3991 | §103 | Final Rejection | 16d overdue | Pending | Aug 12, 2022 |
| 17798334 | CELL CULTURE MANAGEMENT SYSTEM | Integriculture Inc. | KRCHA, MATTHEW D | 1796 | §102 | Non-Final OA | 42d | Pending | Aug 09, 2022 |
| 17797473 | METHODS AND COMPOSITIONS FOR PRODUCTION OF SALINE TOLERANT PLANTS | Luke Young | KUMAR, VINOD | 1663 | §103 | Final Rejection | 4d overdue | Pending | Aug 04, 2022 |
| 17794673 | METHODS AND COMPOSITIONS FOR GENERATING TYPE 1 VESTIBULAR HAIR CELLS | Decibel Therapeutics, Inc. | TRAN, CHRISTINA L | 1637 | §112 | Non-Final OA | 62d | Pending | Jul 22, 2022 |
| 17810022 | METHODS FOR THE TREATMENT OF EPILEPSY | Centre National De La Recherche Scientifique | MEYERING, SHABANA SHABBEER | 1635 | §103 | Non-Final OA | 21d | Pending | Jun 30, 2022 |
| 17786360 | PREPARATION OF HALOGENATED ALKOXYETHANE | Commonwealth Scientific And Industrial Research Organisation | BAHTA, MEDHANIT W | 1692 | §103 | Non-Final OA | 93d overdue | Pending | Jun 16, 2022 |
| 17748323 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN NEURAL PROGENITOR CELLS | Trailhead Biosystems Inc. | TRAN, KHOA NHAT | 1632 | §103 | Final Rejection | 10d overdue | Pending | May 19, 2022 |
| 17742847 | OCULAR DEVICE DELIVERY METHODS AND SYSTEMS | Layerbio, Inc. | PIPIC, ALMA | 1617 | §103 | Final Rejection | 24d overdue | Pending | May 12, 2022 |
| 17775665 | A CORPOREAL COMPRESSION SYSTEM | Coco Industries Pty Ltd. | MOON, MATTHEW RYAN | 3785 | §103 | Non-Final OA | 27d | Pending | May 10, 2022 |
| 17735326 | COCHLEAR OUTER HAIR CELL PROMOTERS AND USES THEREOF | Decibel Therapeutics, Inc. | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §103 | Final Rejection | 34d | Pending | May 03, 2022 |
| 17731112 | METHODS FOR ELECTRO-MECHANICAL TRANSFECTION | Kytopen Corporation | NOBLE, MARCIA STEPHENS | 1632 | §102 | Non-Final OA | 9d | Pending | Apr 27, 2022 |
| 17725271 | BIOREDUCTIVELY-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICALS, THE COMPOSITIONS, AND THEIR APPLICATIONS IN MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA DISEASES INCLUDING CANCER | The Governors of the University of Alberta | DONOHUE, SEAN R | 1618 | §103 | Final Rejection | 29d | Pending | Apr 20, 2022 |
| 17768300 | COMPOSITIONS AND METHODS FOR MODIFYING EUKARYOTIC CELLS | Orchard Therapeutics (Europe) Limited | NOBLE, MARCIA STEPHENS | 1632 | §112 | Non-Final OA | 30d | Pending | Apr 12, 2022 |
| 17715724 | EXTENDED-RELEASE INJECTABLE GEL FORMULATIONS CONTAINING ANGIOTENSIN-(1-7) OLIGOPEPTIDES OR VARIANTS THEREOF | Proneurogen, Inc. | PEEBLES, KATHERINE | 1617 | §103 | Final Rejection | 60d overdue | Pending | Apr 07, 2022 |
| 17766280 | INHIBITOR OF CELL PROLIFERATION IN OBINUTUZUMAB RESISTANT CD20-POSITIVE CANCER, AND MEDICINAL COMPOSITION, MEDICINE, PRODUCTION, METHOD FOR INHIBITING CELL PROLIFERATION, THERAPEUTIC METHOD, TYPE II ANTI-CD20 ANTIBODY, COMPOUNDS, COMBINATION OF SAME, ENHANCER AND INDUCER, EACH RELATING THERETO | Chugai Seiyaku Kabushiki Kaisha | SANG, HONG | 1646 | §102 | Non-Final OA | 29d | Pending | Apr 04, 2022 |
| 17709710 | TOPICAL FORMULATIONS OF 5-ALPHA-REDUCTASE INHIBITORS AND USES THEREOF | Varsona Therapeutics, Inc. | DRAPER, LESLIE A ROYDS | 1629 | §102 | Non-Final OA | 9d | Pending | Mar 31, 2022 |
| 17764003 | METHODS FOR TREATING HYPERPHENYLALANINEMIA | Ptc Therapeutics Mp, Inc. | GAUGER, PAUL RANDALL | 1629 | Other | Final Rejection | 34d | Pending | Mar 25, 2022 |
| 17641904 | METHODS OF TREATING CANCER | Inspirna, Inc. | LADD, CAROLYN LOUISE | 1622 | Other | Final Rejection | 26d overdue | Pending | Mar 10, 2022 |
| 17689117 | METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY | The General Hospital Corporation | LYONS, MARY M | 1645 | §102 | Final Rejection | 14d | Pending | Mar 08, 2022 |
| 17637392 | COMPSTATIN ANALOGUES AND THEIR MEDICAL USES | Zp Spv 3 K/S | COFFA, SERGIO | 1658 | §103 | Non-Final OA | 3d overdue | Pending | Feb 22, 2022 |
| 17586277 | DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY | Xrad Holding Cayman Limited | MAHLUM, JONATHAN DAVIS | 1625 | Other | Non-Final OA | 60d overdue | Pending | Jan 27, 2022 |
| 17629918 | ADOPTIVE TRANSFER OF PLASMACYTOID DENDRITIC CELLS TO PREVENT OR TREAT HAIR LOSS | Tufts Medical Center, Inc. | MIANO, JOSEPH PAUL | 1631 | §103 | Final Rejection | 134d overdue | Pending | Jan 25, 2022 |
| 17629313 | PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF | Caregen Co., Ltd. | NIEBAUER, RONALD T | 1658 | §101 | Final Rejection | 3d overdue | Pending | Jan 21, 2022 |
| 17628617 | COSMETIC COMPOSITIONS AND USES THEREOF | Alumier Labs, Inc. | JOHNSON, DANIELLE D | 1617 | §103 | Final Rejection | 57d | Pending | Jan 20, 2022 |
| 17579067 | MICROBIOME REGULATORS AND RELATED USES THEREOF | DSM Nutritional Products, LLC | ALAM, AYAAN A | 1611 | §103 | Non-Final OA | 31d overdue | Pending | Jan 19, 2022 |
| 17627975 | SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING CANCER | The General Hospital Corporation | LEE, YIE CHIA | 1642 | §103 | Final Rejection | 78d | Pending | Jan 18, 2022 |
| 17627854 | HOST-INDEPENDENT EXPRESSION OF BACTERIOPHAGES | Technische Universität München | WANG, RUIXUE | 1672 | §103 | Non-Final OA | 19d overdue | Pending | Jan 18, 2022 |
| 17573730 | ANTI-CD40 ANTIBODIES AND USES THEREOF | Emory University | YU, MISOOK | 1641 | §112 | Non-Final OA | 103d overdue | Pending | Jan 12, 2022 |
| 17626486 | INHIBITORS OF TYROSINE KINASE | Bridgene Biosciences, Inc. | SAMSELL, RILLA MARIE | 1624 | §103 | Final Rejection | 33d | Pending | Jan 11, 2022 |
| 17597351 | METHODS FOR THE TREATMENT OF EPILEPSY | Centre National De La Recherche Scientifique | MEYERING, SHABANA SHABBEER | 1635 | §103 | Final Rejection | 5d | Pending | Jan 04, 2022 |
| 17617731 | MEMBRANE ATTACK COMPLEXES AND USES THEREOF | The Brigham And Women'S Hospital, Inc. | QIAN, CELINE X | 1637 | §103 | Final Rejection | 60d overdue | Pending | Dec 09, 2021 |
| 17616144 | Kisspeptins to Predict and Treat Delayed Puberty | Children`S Medical Center Corporation | DABKOWSKI, ERINNE R | 1654 | §103 | Final Rejection | 142d overdue | Pending | Dec 02, 2021 |
| 17615410 | TUMOR CELL-DERIVED EXOSOMES AND THEIR APPLICATIONS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | DENT, ALANA HARRIS | 1643 | §103 | Final Rejection | 21d | Pending | Nov 30, 2021 |
| 17510981 | METHOD FOR OBTAINING IMMUNO-STIMULATORY DENDRITIC CELLS | Yale University | SCHUBERG, LAURA J | 1631 | Other | Non-Final OA | 44d overdue | Pending | Oct 26, 2021 |
| 17598029 | SYSTEMS AND METHODS FOR PRODUCING COLLAGEN 7 COMPOSITIONS | Phoenix Tissue Repair, Inc. | SABILA, MERCY HELLEN | 1654 | §103 | Non-Final OA | 89d overdue | Pending | Sep 24, 2021 |
| 17440081 | CARDIOMYOCYTE PROLIFERATION | The Queensland Institute of Medical Research | TRAN, KHOA NHAT | 1632 | §112 | Final Rejection | 37d overdue | Pending | Sep 16, 2021 |
| 17405706 | PHOSPHONOACETATE GAPMER OLIGONUCLEOTIDES | Roche Innovation Center Copenhagen A/S | ZAHORIK, AMANDA MARY | 1636 | §103 | Final Rejection | 89d overdue | Pending | Aug 18, 2021 |
| 17427453 | ANTIMICROBIAL ENDOLYSIN POLYPEPTIDES, COMPOSITIONS AND FORMULATIONS | Axitan Holdings, Inc. | HELLMAN, KRISTINA M | 1654 | §101 | Non-Final OA | 7d | Pending | Jul 30, 2021 |
| 17426433 | A PROCESS FOR PRODUCING SYNTHETIC JET FUEL | Greenfield Global Inc. | STEIN, MICHELLE | 1771 | §103 | Non-Final OA | 100d overdue | Pending | Jul 28, 2021 |
| 17310235 | OLIGONUCLEOTIDES AND METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | The Schepens Eye Research Institute, Inc. | PYLA, EVELYN Y | 1633 | §103 | Final Rejection | 5d overdue | Pending | Jul 27, 2021 |
| 17424985 | B CELL IMMUNOTHERAPY | Holy Cross Hospital, Inc. | TICHY, JENNIFER M.H. | 1653 | §103 | Non-Final OA | 17d overdue | Pending | Jul 22, 2021 |
| 17425058 | METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF OCULAR DISEASES AND CONDITIONS | Tufts Medical Center, Inc. | TRAN, CHRISTINA L | 1637 | §112 | Final Rejection | 132d overdue | Pending | Jul 22, 2021 |
| 17413223 | COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC AGENTS ACROSS THE ROUND WINDOW MEMBRANE | Decibel Therapeutics, Inc. | REYNOLDS, FRED H | 1658 | §103 | Non-Final OA | 28d | Pending | Jun 11, 2021 |
| 17297228 | SOLID STATE BATTERIES | President and Fellows of Harvard College | LU, ZIHENG NMN | 1752 | §103 | Non-Final OA | 6d | Pending | May 26, 2021 |
| 17292107 | PATIENT-DERIVED AMYLOID XENOGRAFT NON-HUMAN ANIMAL MODEL | Neurimmune AG | LEVIN, JOEL D | 1633 | §103 | Non-Final OA | 28d | Pending | May 07, 2021 |
| 17291192 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISORDERS | Obseva S.A. | WELLS, LAUREN QUINLAN | 1622 | Other | Non-Final OA | 10d overdue | Pending | May 04, 2021 |
| 17279691 | FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES | Zealand Pharma A/S | BEANE, RANDALL L | 1654 | §103 | Non-Final OA | 29d | Pending | Mar 25, 2021 |
| 17276252 | FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES | Zealand Pharma A/S | BEANE, RANDALL L | 1654 | Other | Final Rejection | 3d overdue | Pending | Mar 15, 2021 |
| 17257055 | COMPOSITIONS AND METHODS FOR REDUCTION OF LIPOPROTEIN A FORMATION AND TREATMENT OF AORTIC VALVE SCLEROSIS AND AORTIC STENOSIS | Abcentra, LLC | FONTAINHAS, AURORA M | 1675 | §103 | Final Rejection | 22d | Pending | Dec 30, 2020 |
| 17056368 | SPLICE MODULATING OLIGONUCLEOTIDES TARGETING RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND METHODS OF USE | Lifesplice Pharma LLC | JOHNSON, ALLISON MARIE | 1638 | §103 | Non-Final OA | 77d overdue | Pending | Nov 17, 2020 |
| 16610357 | DEVICES AND METHODS FOR SENSOR-ENHANCED NEEDLE PLACEMENT | Rockport Medical Technologies LLC | DARB, HAMZA A. | 3783 | §103 | Non-Final OA | 77d overdue | Pending | Nov 01, 2019 |
| 15771043 | NOVEL POLYPEPTIDES WITH IMPROVED PROTEOLYTIC STABILITY, AND METHODS OF PREPARING AND USING SAME | Tufts Medical Center, Inc. | REYNOLDS, FRED H | 1658 | §103 | Non-Final OA | 73d overdue | Pending | Apr 25, 2018 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial